Compare 10X Genomics Inc (TXG) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Wells Fargo & Co — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Wells Fargo & Co trades at $87.8 (market cap $261.45B). The key difference: Wells Fargo & Co is far larger — about 47.7× 10X Genomics Inc's market cap, and Wells Fargo & Co pays a 2.09% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | WFC | |
|---|---|---|
Market Cap | $5.48B | $261.45B |
Sector | Health | Financials |
52-Week High | $45.80 | $96.40 |
52-Week Low | $11.34 | $73.42 |
Enterprise Value | $5.02B | — |
Dividend Yield | — | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
